In the BioHarmony Drug Report Database
Leuprolide
Eligard, Fensolvi, Lupron, Lupron Depot, Lupron Depot-ped, Lutrate Depot, Viadur (leuprolide) is a protein pharmaceutical. Leuprolide was first approved as Eligard on 1985-04-09. It is used to treat breast neoplasms, endometrial neoplasms, endometriosis, infertility, and leiomyoma amongst others in the USA. The pharmaceutical is active against gonadotropin-releasing hormone receptor. Lupron depot’s patents are valid until 2031-02-05 (FDA).
Trade Name
|
Eligard, Fensolvi, Lupron, Lupron Depot, Lupron Depot-ped, Lutrate Depot, Viadur |
|---|---|
Common Name
|
leuprolide |
ChEMBL ID
|
CHEMBL1201199 |
Indication
|
breast neoplasms, endometrial neoplasms, endometriosis, infertility, leiomyoma, ovarian neoplasms, precocious puberty, prostatic hyperplasia, prostatic neoplasms |
Drug Class
|
Gnrh analogue; GnRH agonist; Antigonadotropin |
Image (chem structure or protein)